Daklinza

Bristol-Myers wins approval in China for oral treatment for chronic hepatitis C virus
Marketwatch
Fri, 04/28/17 - 10:32 am
Bristol-Myers Squibb
China
hepatitis C
Daklinza
BMY’s Hepatitis C Franchise May See a Drop in Revenues in 2016
Market Realist
Thu, 12/22/16 - 10:26 am
Bristol-Myers Squibb
hepatitis C
Daklinza
Sunvepra
The Most Expensive Drugs of 2016
Motley Fool
Mon, 12/19/16 - 11:32 am
drug pricing
Gilead Sciences
Harvoni
Sovaldi
H.P. Acthar
Mallinckrodt
Shire
Cinryze
Daklinza
Bristol-Myers Squibb
Bristol-Myers Lets Low-Income Countries Copy Hepatitis C Pills
Bloomberg
Mon, 11/23/15 - 10:14 am
Bristol-Myers Squibb
hepatitis C
Medicines Patent Pool
Daklinza
Can Daklinza profit from a set of niche hep C uses? BMS may soon find out
Fierce Pharma Marketing
Wed, 10/7/15 - 10:00 am
Daklinza
Bristol-Myers Squibb
hepatitis C
Bristol-Myers snags a hep C approval to piggyback on Gilead's blockbuster
Fierce Biotech
Mon, 07/27/15 - 01:28 pm
Bristol-Myers Squibb
Gilead Sciences
hepatitis C
Daklinza
Sovaldi
AbbVie, Bristol-Myers get FDA nod for hep C treatments
Yahoo/Reuters
Fri, 07/24/15 - 05:40 pm
AbbVie
Bristol-Myers Squibb
hepatitis C
FDA
Technivie
Daklinza
Bristol-Myers Squibb Has A Real Shot At A Home Run In Hepatitis C
Seeking Alpha
Thu, 01/8/15 - 08:21 am
Bristol-Myers Squibb
hepatitis C
Daklinza
Sunvepra
Bristol-Myers Plan to Widen Access to its Hep C Drug is Criticized
WSJ Pharmalot
Mon, 11/3/14 - 03:40 pm
Bristol-Myers Squibb
hepatitis C
Daklinza
daclatasvir
Bristol-Myers gets the approval Gilead didn't want: Daklinza + Sovaldi for hep C
Fierce Pharma Marketing
Wed, 08/27/14 - 10:19 am
Bristol-Myers Squibb
Gilead Sciences
hepatitis C
Daklinza
Sovaldi
Bristol-Myers gets positive Hep C opinion from EMA committee
Marketwatch
Fri, 06/27/14 - 09:51 am
Daklinza
hepatitis C
Europe
Bristol-Myers Squibb